NEW YORK - Pfizer-BioNTech on Friday requested to expand the emergency use of its COVID-19 vaccine in the United States for older children ages 12 to 15.The request asks the U.S.
Food and Drug Administration to amend its Emergency Use Authorization, which was originally granted in December for people ages 16 and older."Pending regulatory decision, our hope is to make this vaccine available to the 12-15-year-old age group before the start of the 2021 school year," Pfizer said in a statement.Pfizer, which developed the two-dose vaccine with its German partner BioNTech, said it plans to submit a similar request to European regulators and other health officials worldwide in the coming days.FILE - A nurse prepares a dose of the Pfizer/BioNTech.